Evidence map›Paper›PMID 37761124›Full record

ArticleFoods (Basel, Switzerland)2023

Inhibitory Mechanism of Quercimeritrin as a Novel α-Glucosidase Selective Inhibitor.

Fengyu Guo, Jie An, Minlong Wang, Weibo Zhang, Chong Chen, Xueying Mao, Siyuan Liu, Pengjie Wang, Fazheng Ren

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. SuFEx-Enabled Reprogramming of Flavonoids for Selective α-Glucosidase Covalent Inhibition.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Fengyu GuoCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Jie AnDepartment of Nutrition and Health, China Agricultural University, Beijing 100083, China.ORCID 0000-0002-1521-009X
Minlong WangDepartment of Nutrition and Health, China Agricultural University, Beijing 100083, China.
Weibo ZhangDepartment of Nutrition and Health, China Agricultural University, Beijing 100083, China.
Chong ChenDepartment of Nutrition and Health, China Agricultural University, Beijing 100083, China.
Xueying MaoCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.ORCID 0000-0001-6306-7534
Siyuan LiuDepartment of Nutrition and Health, China Agricultural University, Beijing 100083, China.
Pengjie WangDepartment of Nutrition and Health, China Agricultural University, Beijing 100083, China.
Fazheng RenCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
China Agricultural University · CN

Funding

National Key Research and Development Program of China 2021YFD2101000/2021YFD2101001
6 · The paper itself

Abstract

In this study, 12 flavonoid glycosides were selected based on virtual screening and the literature, and Quercimeritrin was selected as the best selective inhibitor of α-glucosidase through in vitro enzyme activity inhibition experiments. Its IC

Indexed as

flavonoid glycosidesselective inhibitorα-amylaseα-glucosidase

Identifiers

PMID37761124
PMCPMC10528180
OpenAlexW4386741437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.